Jasper Therapeutics (JSPR) executive compensation, 2026 proxy

Ronald Martell, Former Chief Executive Officer and President, was paid $2.5M in 2025, down 22% from $3.2M the year before.

Filed
June 15, 2026
Annual meeting
July 31, 2026
Pay year
2025
Named executives
4
CEO total pay
$2.5M-22% vs prior year
Prior say-on-pay support
94%of votes cast
Mahal target bonus
45%2025 annual base salary
Cross target bonus
45%2025 annual base salary
Martell target bonus
50%2025 annual base salary
Tucker severance
$544,810Included COBRA premiums

How Martell was paid

$2.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary29%Option awards71%

Named executive officers

ExecutiveTotal
Jeet MahalChief Executive Officer and President; Former Chief Operating Officer$1,289,599
Herb CrossChief Financial Officer and Corporate Secretary$1,283,474
Ronald MartellFormer Chief Executive Officer and President$2,494,099
Edwin Tucker, M.D.Former Chief Medical Officer$1,537,032

What changed and why

  • 2,494,099 was Ronald Martell’s 2025 total compensation, down from 3,215,003 in 2024.
  • 1,766,827 was Martell’s 2025 option-award value, with no non-equity incentive compensation reported.
  • 1,289,599 was Jeet Mahal’s 2025 total compensation, including 112,050 in non-equity incentive compensation.
  • 544,810 of Edwin Tucker’s 2025 compensation consisted of severance benefits, including COBRA premiums.
  • 50%50% was Mahal’s 2026 target bonus percentage after becoming Chief Executive Officer and President.
  • 93.7%93.7% of votes supported the company’s 2024 executive compensation at the 2025 annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.